Login
$LMED
$0.43 -$0.01 (2.25%) Close

Balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Cash
Total current assets
Intangible assets
Total assets
Accounts payable and accrued liabilities
Notes payable - related party
Notes payable
Convertible notes payable
Total current liabilities
Total liabilities
Preferred stock, value
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Total preferred stock, value
Common stock, $0.001 par value, 700,000,000 shares authorized, 36,134,795 and 44,296,895 and shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid in capital
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities and stockholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support